MAPT and Parkinson disease: It was demonstrated that while PD was associated with decreased CSF α-syn, Aβ1–42, t-tau, and p-tau compared to controls, no difference was observed in the level of these biomarkers between PD and SWEDD patients (Yu and Li, 2021).